Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT03437941 · TERMINATED
Trial details
- NCT number
- NCT03437941
- Sponsor
- Corcept Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2021-10-13
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.